Gandeeva
5 known investors
Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces. The company applies this drug-discovery approach to develop precision medicines against targets such as protein-protein complexes, nucleic acid-protein complexes, and membrane proteins.
AI & Machine LearningBiotechDeep TechDigital Health
Founders & leadership
SS
Sriram SubramaniaminFounder and CEO, Gandeeva Therapeutics Inc.
Investors Β· 5
In the news
Frequently asked questions
- What does Gandeeva do?
- Gandeeva Therapeutics uses AI, machine learning, and atomic-resolution cryo-EM imaging to map druggable protein interactions and design molecular glues that bind at specific protein interfaces. The company applies this drug-discovery approach to develop precision medicines against targets such as protein-protein complexes, nucleic acid-protein complexes, and membrane proteins.
- Who founded Gandeeva?
- Gandeeva was founded by Sriram Subramaniam.
- Who are Gandeeva's investors?
- Gandeeva's investors include Air Street Capital, Lux Capital, Obvious Ventures, Amgen Ventures, Leaps by Bayer.